Klingman & Associates, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1662449
New York, NY
Position in VRTX
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$271,711
+$35,492 QoQ
Shares Held
547
+3.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#1,276
of 1,735 holders
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Klingman & Associates, LLC holds $511,150 across 2 Biotechnology names. VRTX ranks #1 (53.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
547 | $271,711 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
384 | $239,439 |
All Filings in VRTX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $271,711 | 547 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $236,219 | 529 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $210,812 | 465 | Shares | Sole | 2026-01-29 | |
| 2025-06-30 | $207,463 | 466 | Shares | Sole | 2025-07-30 | |
| No filing history on record for this holder in this stock. | ||||||